Our Company

Over Seven Decades of Growth Fueled by a Dedication to Quality



Founded in 1946 by H.N. “Wally” Walsdorf, Mission Pharmacal Company begins to produce products with a commitment to using the highest quality ingredients. Mr. Walsdorf’s philosophy: “A pharmaceutical product is no better than the purity and quality of the raw materials that go into its production.” That philosophy still guides Mission today. Mission’s first product, IROMIN®, is a hematinic that helped increase the hemoglobin content of the blood.



Mission continues to grow and expands its operations in San Antonio throughout the ‘50s, opening its first manufacturing facility early in the decade. More products are introduced and more employees added.


The decade is marked by rapid expansion of the Mission sales area across Texas and by the mid-‘60s throughout the Southwest. More manufacturing capabilities are added to keep up with the increased demand for Mission products. Mission introduces a unique tablet shape making their pills easier to swallow than a traditional capsule. Wally’s son Neill joins the organization and helps oversee the day-to-day operations of the company.


The ‘70s sees Mission step onto the national stage with rapid expansion across America. In addition to territorial expansion, Mission widens its product offerings to include Ob/Gyn offerings, prenatal supplements, and a range of over-the-counter products. The company also enters the sports medicine arena with a pain reliever called SUPAC®.


Developed by Mission, Citracal® became a leading calcium supplement worldwide and helps expand Mission’s reach around the globe. Mission also introduces a number of revolutionary medications for the treatment of kidney stone disease, including Urocit®-K (Potassium Citrate) and Lithostat® (Acetohydroxamic Acid). These and other products make Mission the leader in the medical management of kidney stone disease, a role that continues today.


To meet exploding demand for its products, Mission opens a 100,000 square foot manufacturing center in Boerne, Texas, making Mission an advanced manufacturer of pharmaceuticals. Today, the Boerne complex has expanded to more than 300,000 square feet of manufacturing, distribution, and R&D floor space. Leadership extends to the third generation with Neill B. Walsdorf Jr. taking over as president of the company.


Mission completes construction of a 30,000 square foot R&D facility in Boerne, Texas. In addition to continuing to expand its facilities, Mission adds additional capabilities to its production operations and can now manufacture and package powders, tablets, solutions, creams, lotions, gels, and suspensions. The introduction of high capacity equipment allows Mission to produce more than 1.5 billion tablets a year using over 450,000 pounds of raw material per month.


As it has for more than 75 years, the company remains committed to introducing innovative, science-based products. Focusing on: women’s health, urology, and dermatology, Mission uses expertise and imagination as well as the passion and determination of its people to produce the highest quality pharmaceutical and consumer products available.